Changes in epileptogenicity biomarkers after stereotactic thermocoagulation
- PMID: 34272883
- DOI: 10.1111/epi.16989
Changes in epileptogenicity biomarkers after stereotactic thermocoagulation
Abstract
Objective: Stereo-electroencephalography (SEEG)-guided radiofrequency thermocoagulation (RF-TC) aims at modifying epileptogenic networks to reduce seizure frequency. High-frequency oscillations (HFOs), spikes, and cross-rate are quantifiable epileptogenic biomarkers. In this study, we sought to evaluate, using SEEG signals recorded before and after thermocoagulation, whether a variation in these markers is related to the therapeutic effect of this procedure and to the outcome of surgery.
Methods: Interictal segments of SEEG signals were analyzed in 38 patients during presurgical evaluation. We used an automatized method to quantify the rate of spikes, rate of HFOs, and cross-rate (a measure combining spikes and HFOs) before and after thermocoagulation. We analyzed the differences both at an individual level with a surrogate approach and at a group level with analysis of variance. We then evaluated the correlation between these variations and the clinical response to RF-TC and to subsequent resective surgery.
Results: After thermocoagulation, 19 patients showed a clinical improvement. At the individual level, clinically improved patients more frequently had a reduction in spikes and cross-rate in the epileptogenic zone than patients without clinical improvement (p = .002, p = .02). At a group level, there was a greater decrease of HFOs in epileptogenic and thermocoagulated zones in patients with clinical improvement (p < .05) compared to those with no clinical benefit. Eventually, a significant decrease of all the markers after RF-TC was found in patients with a favorable outcome of resective surgery (spikes, p = .026; HFOs, p = .03; cross-rate, p = .03).
Significance: Quantified changes in the rate of spikes, rate of HFOs, and cross-rate can be observed after thermocoagulation, and the reduction of these markers correlates with a favorable clinical outcome after RF-TC and with successful resective surgery. This may suggest that interictal biomarker modifications after RF-TC can be clinically used to predict the effectiveness of the thermocoagulation procedure and the outcome of resective surgery.
Keywords: epileptogenic biomarkers; stereo-electroencephalography; thermocoagulation.
© 2021 International League Against Epilepsy.
References
REFERENCES
-
- Catenoix H, Bourdillon P, Guénot M, Isnard J. The combination of stereo-EEG and radiofrequency ablation. Epilepsy Res. 2018;142:117-20.
-
- Guenot M, Isnard J, Catenoix H, Mauguière F, Sindou M. SEEG-guided RF-thermocoagulation of epileptic foci: a therapeutic alternative for drug-resistant non-operable partial epilepsies. Adv Tech Stand Neurosurg. 2011;36:61-78.
-
- Cossu M, Cardinale F, Casaceli G, Castana L, Consales A, D’Orio P, et al. Stereo-EEG-guided radiofrequency thermocoagulations. Epilepsia. 2017;58:66-72.
-
- Wang D, Wei P, Shan Y, Ren L, Wang Y, Zhao G. Optimized stereoelectroencephalography-guided radiofrequency thermocoagulation in the treatment of patients with focal epilepsy. Ann Transl Med. 2020;8:15.
-
- Bourdillon P, Devaux B, Job-Chapron AS, Isnard J. SEEG-guided radiofrequency thermocoagulation. Neurophysiol Clin. 2018;48:59-64.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources